Brand Name | Status | Last Update |
---|---|---|
oxaliplatin | ANDA | 2025-02-24 |
Code | Description |
---|---|
J9263 | Injection, oxaliplatin, 0.5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 7 | 25 | 19 | 1 | 3 | 49 |
Colonic neoplasms | D003110 | — | C18 | 1 | 1 | 1 | 1 | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | 15 | 2 | — | 1 | 18 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 8 | 8 | — | — | 16 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 7 | 12 | 1 | — | 2 | 16 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 8 | 6 | — | — | 13 |
Carcinoma | D002277 | — | C80.0 | 2 | 9 | 2 | — | — | 12 |
Neoplasms | D009369 | — | C80 | 2 | 7 | 3 | — | — | 10 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 8 | 1 | — | — | 10 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 8 | 1 | — | — | 9 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 4 | 2 | — | — | 7 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | 1 | 5 | 1 | — | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | D000230 | — | — | 2 | 16 | — | — | 1 | 18 |
Rectal neoplasms | D012004 | — | — | 3 | 12 | — | — | 2 | 15 |
Esophageal neoplasms | D004938 | — | C15 | 1 | 8 | — | — | 2 | 10 |
Head and neck neoplasms | D006258 | — | — | — | 7 | — | — | — | 7 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 6 | — | — | — | 6 |
Biliary tract neoplasms | D001661 | — | C24.9 | — | 5 | — | — | — | 5 |
Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 1 | 4 | — | — | — | 4 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 2 | — | — | — | 3 |
Urinary bladder neoplasms | D001749 | — | C67 | 1 | 3 | — | — | — | 3 |
Squamous cell carcinoma | D002294 | — | — | — | 3 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Peritoneal neoplasms | D010534 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | — | — | — | 1 | 1 |
Drug common name | Oxaliplatin |
INN | oxaliplatin |
Description | Oxaliplatin, sold under the brand name Eloxatin among others, is a cancer medication (platinum-based antineoplastic class) used to treat colorectal cancer. It is given by injection into a vein.
|
Classification | Small molecule |
Drug class | antineoplastics (platinum derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 61825-94-3 |
RxCUI | — |
ChEMBL ID | CHEMBL414804 |
ChEBI ID | — |
PubChem CID | 11947679 |
DrugBank | DB00526 |
UNII ID | 04ZR38536J (ChemIDplus, GSRS) |